Amyris (AMRS) Enters Extended Collaboration with Kuraray for ß-Farnesene in LFR
- Wall Street dips on Trump protectionism, Qualcomm drag
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- After-Hours Stock Movers 1/23: (REXX) (MRCY) (SYNC) Higher; (FSM) (OCUL) (CASC) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Amyris, Inc. (Nasdaq: AMRS) announced that it has executed with its long-time partner Kuraray Co., LTD a multi-year extension to their collaboration agreement for the use of Amyris’s Biofene branded ß-Farnesene in liquid farnesene rubber (“LFR”) and farnesene-based elastomer applications. This collaboration, which originally began in 2011, features increased farnesene supply to Kuraray and joint marketing of products to industry and end-customers.
Amyris’s sugar cane-derived Biofene forms the basis for a wide range of products varying from specialty products such as cosmetics, perfumes, detergents and industrial lubricants, to transportation fuels such as diesel and jet fuel. As a tailor made pure hydrocarbon it provides numerous advantages when compared to petroleum-based oils and chemicals and is renewable, contributing to a sustainable future.
Farnesene Fueling Better Products Across the World – Including Tires
Kuraray’s recent technological successes with rubber containing farnesene includes an enhanced synthetic additive for tire manufacturers. Its novel LFR and other farnesene- containing rubber materials add substantial grip and cornering capability to tires, particularly in cold, snow and ice conditions. In addition, its hydrogenated styrenic-farnesene copolymer (“HSFC”) has demonstrated superior shock absorption in products ranging from footwear to specialty construction materials.
“We are delighted to extend our relationship with Kuraray,” said John Melo, CEO of Amyris. “Introducing a novel molecule to industry requires patience and creativity. However, Kuraray’s technical expertise and customer relationships have reached the point where their products are now becoming mainstream and this, in turn, is fueling further broadening market adoption of our farnesene for a variety of products.”
“Kuraray has many years’ experience working with farnesene, which we believe has many end-market applications,” said Mr. Kenichi Abe, President of Kuraray’s Isoprene business. “Our collaboration with Amyris and their breakthrough-ability to produce farnesene at industrial scale, and at competitive price, enables Kuraray to provide its customers products with superior performance and that are renewably sourced.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GlobalStar (GSAT) Announces Departure of COO David Kagan
- Chemical Financial (CHFC) Names Jeffrey Tate to Board of Directors
- Merus N.V. (MRUS) Enters Strategic Research Collaboration with Incyte (INCY); Includes Upfront Payment of $120M
Create E-mail Alert Related CategoriesCorporate News, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!